Cargando…

Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses

The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the...

Descripción completa

Detalles Bibliográficos
Autores principales: Okodo, Mitsuaki, Okayama, Kaori, Sasagawa, Toshiyuki, Teruya, Koji, Settsu, Rei, Mizuno, Shuichi, Ishii, Yasuyoshi, Oda, Mizue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487609/
https://www.ncbi.nlm.nih.gov/pubmed/37685959
http://dx.doi.org/10.3390/ijms241713151
_version_ 1785103283827769344
author Okodo, Mitsuaki
Okayama, Kaori
Sasagawa, Toshiyuki
Teruya, Koji
Settsu, Rei
Mizuno, Shuichi
Ishii, Yasuyoshi
Oda, Mizue
author_facet Okodo, Mitsuaki
Okayama, Kaori
Sasagawa, Toshiyuki
Teruya, Koji
Settsu, Rei
Mizuno, Shuichi
Ishii, Yasuyoshi
Oda, Mizue
author_sort Okodo, Mitsuaki
collection PubMed
description The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the cervix, whereas the preferential infection site for low-risk (LR) types is not well defined. The determination of HPV tropism when using cytology samples can be uncertain since it is difficult to avoid contamination of cell samples between the cervix and the vagina. Herein, cell samples were carefully collected by independently scraping the cervix and vagina, after which the HPV types were determined. HPV tissue tropism was determined by considering what HPV types were positive at only one of the sites (the cervix or the vagina) as the viruses that preferentially infected that site. This method revealed that all LR types were only identified in vaginal samples, whereas 87% of HR types were identified in cervical sites. Thus, LR types may preferentially infect the vagina, whereas HR types infect the cervix. These findings suggest that preferential tissue tropism of certain HPV types is a probable factor for malignant progression.
format Online
Article
Text
id pubmed-10487609
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104876092023-09-09 Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses Okodo, Mitsuaki Okayama, Kaori Sasagawa, Toshiyuki Teruya, Koji Settsu, Rei Mizuno, Shuichi Ishii, Yasuyoshi Oda, Mizue Int J Mol Sci Article The oncogenic potential of human papillomavirus (HPV) may be used to determine the tissue tropism of each HPV type. Cervical cancer develops in the squamo-columar junction of the cervices, and most lesions are induced by high-risk (HR) HPV types. This suggests that HR types preferentially infect the cervix, whereas the preferential infection site for low-risk (LR) types is not well defined. The determination of HPV tropism when using cytology samples can be uncertain since it is difficult to avoid contamination of cell samples between the cervix and the vagina. Herein, cell samples were carefully collected by independently scraping the cervix and vagina, after which the HPV types were determined. HPV tissue tropism was determined by considering what HPV types were positive at only one of the sites (the cervix or the vagina) as the viruses that preferentially infected that site. This method revealed that all LR types were only identified in vaginal samples, whereas 87% of HR types were identified in cervical sites. Thus, LR types may preferentially infect the vagina, whereas HR types infect the cervix. These findings suggest that preferential tissue tropism of certain HPV types is a probable factor for malignant progression. MDPI 2023-08-24 /pmc/articles/PMC10487609/ /pubmed/37685959 http://dx.doi.org/10.3390/ijms241713151 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Okodo, Mitsuaki
Okayama, Kaori
Sasagawa, Toshiyuki
Teruya, Koji
Settsu, Rei
Mizuno, Shuichi
Ishii, Yasuyoshi
Oda, Mizue
Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title_full Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title_fullStr Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title_full_unstemmed Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title_short Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses
title_sort preferential tissue sites of different cancer-risk groups of human papillomaviruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487609/
https://www.ncbi.nlm.nih.gov/pubmed/37685959
http://dx.doi.org/10.3390/ijms241713151
work_keys_str_mv AT okodomitsuaki preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT okayamakaori preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT sasagawatoshiyuki preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT teruyakoji preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT settsurei preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT mizunoshuichi preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT ishiiyasuyoshi preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses
AT odamizue preferentialtissuesitesofdifferentcancerriskgroupsofhumanpapillomaviruses